The move comes after a report linked the drug to an increased fatality rate among those with coronavirus.
Amid HCQ row, AIIMS Director explains two 'different aspects' of using the anti-malarial drug
ANI
Director of All India Institute of Medical Sciences (AIIMS) Delhi, Dr Randeep Guleria said that there are higher chances of..
